The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series E | Alive

Total Raised


Last Raised

$305.4M | 1 yr ago

About Medbanks Network Technology

Medbanks is an oncology data platform in the field of cancer. It develops intelligent diagnosis and treatment systems, as well as comprehensive solutions to improve the level of tumor diagnosis and treatment and the efficiency of doctors' clinical work.

Medbanks Network Technology Headquarter Location

Building 17, Xinqiwang Office Building, No.1 Dongdadi Street, Dongcheng District

Beijing, Beijing,


+86 010-82291369

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Medbanks Network Technology

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Medbanks Network Technology in 6 CB Insights research briefs, most recently on May 26, 2020.

Expert Collections containing Medbanks Network Technology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Medbanks Network Technology is included in 4 Expert Collections, including Future Unicorns 2019.


Future Unicorns 2019

50 items


Digital Health 150

300 items

2019's cohort of the most promising digital health startups transforming the healthcare industry


Digital Health

13,255 items



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Latest Medbanks Network Technology News

China: CATL (A), Qingdao Ainnovation Technology Group Co Ltd, Medbanks Network Technology, Postal Savings Bank of China, China Education Group, Asia High Yield Bond Index and more

Jan 27, 2022

China News, Data, Media Intelligence and Insights Search for: Source: News Snapshot: In today’s briefing: - Contemporary Amperex Technology – King of the Overweights - Qingdao AInnovation Technology Group IPO Trading – Lukewarm Subscription Rates, Peers Have Corrected - Pre-IPO Medbanks Network Technology – Conservative About the Outlook - China Banks – Credit Quality Snapshot Ahead of 4Q21 - China Education Group (839 HK): Further Regulatory Headwinds? - Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers Before it’s here, it’s on Smartkarma

Medbanks Network Technology Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Medbanks Network Technology Rank

  • When was Medbanks Network Technology founded?

    Medbanks Network Technology was founded in 2014.

  • Where is Medbanks Network Technology's headquarters?

    Medbanks Network Technology's headquarters is located at Building 17, Xinqiwang Office Building, No.1 Dongdadi Street, Dongcheng District, Beijing.

  • What is Medbanks Network Technology's latest funding round?

    Medbanks Network Technology's latest funding round is Series E.

  • How much did Medbanks Network Technology raise?

    Medbanks Network Technology raised a total of $546.47M.

  • Who are the investors of Medbanks Network Technology?

    Investors of Medbanks Network Technology include Tencent Holdings, Wu Capital, Jeneration Capital, 5Y Capital, Forebright Capital Management and 8 more.

  • Who are Medbanks Network Technology's competitors?

    Competitors of Medbanks Network Technology include Evidation.

You May Also Like

Medable Logo

Medable is a decentralized clinical trial software company. The company's Software-as-a-Service (SaaS) cloud platform aims to provide a path to secure, HIPAA-compliant healthcare applications for researchers, startups, pharma, payers, and academia. This platform allows for supporting patient engagement clinical applications, storing personal health information, and complying with HIPAA and other regulations. Medable aims to enable patient-generated data to drive clinical research, healthcare delivery, and personalized and predictive medicine.

Tempus Logo

Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility and use. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine learning platform. It provides genomic sequencing services and molecular and therapeutic data analysis to empower physicians to make real-time, data-driven decisions.


Neurocast is a 24/7 digital biomarker for measuring patients' performance. Neurokeys combines keystroke dynamics data with sensor data, health data from a smartphone and various open datasets. This enables the company to analyze step and staircase counters to provide insights in physical fatigue.


TriNetX is the global health research network that optimizes clinical research and enables discoveries through the creation of real-world evidence. TriNetX combines real-time access to longitudinal clinical data with analytics to answer complex research questions.


MediMergent is a data collection and analytics company focused on Real-World Data (RWD) and Real-World Evidence (RWE) related to patients’ health status. MediMergent has built and deployed a digital platform that collects RWD from customized patient surveys, medical records, health insurance claims and billing data, pharmacy prescriptions and refill data, and, where appropriate, information from wearable medical devices and apps. MediMergent combines this data, acquired directly from the patients, that relate to first-hand accounts of their perceived risk versus benefit relationship for select medications, to generate a unique set of data or evidence (RWE) related to improve outcomes and reduce costs of healthcare. Using proprietary algorithms, MediMergent produces data that can be used by the entire healthcare ecosystem including prescribers, pharmacists, health insurers, pharmaceutical companies, corporations, regulators and importantly, patients.

Aetion Logo

Aetion delivers real-world evidence for life sciences companies, payers, at-risk providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce rapid and scientifically validated answers on treatments, costs, and outcomes. Aetion informs health care's most critical decisions - what works best, for whom, and when - to guide treatment development, commercialization, and payment values into health care's modern era.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.